Prevalence and outcomes of vascular cognitive impairment. Vascular Cognitive Impairment Investigators of the Canadian Study of Health and Aging
- PMID: 10668712
- DOI: 10.1212/wnl.54.2.447
Prevalence and outcomes of vascular cognitive impairment. Vascular Cognitive Impairment Investigators of the Canadian Study of Health and Aging
Abstract
Objective: To assess the importance of vascular cognitive impairment and its three subgroups (cognitive impairment, no dementia; vascular dementia; and AD with a vascular component) to the prevalence and burden of cognitive impairment in elderly people.
Background: Vascular lesions may produce a spectrum of cognitive changes. Omitting elderly patients whose cognitive impairment falls short of dementia (vascular cognitive impairment, no dementia) may give a falsely low indication of the prevalence and burden of disease. To test this proposition, we compared the rates of adverse outcomes for patients with no cognitive impairment, vascular cognitive impairment (and its subgroups), and probable AD.
Methods: The Canadian Study of Health and Aging is a prospective cohort study of 10,253 randomly selected community-dwelling and institution-dwelling respondents aged 65 years or older. In the community, all participants (n = 9,008) were screened for cognitive impairment; those who screened positive and a sample of those who screened negative received a clinical assessment (n = 1,659). All patients living in institutions received a clinical assessment (n = 1,255). Participants were reassessed 5 years after the original survey.
Results: Vascular cognitive impairment without dementia was the most prevalent form of vascular cognitive impairment among those aged 65 to 84 years. Rates of institutionalization and mortality for those with vascular cognitive impairment were significantly higher than those of people who had no cognitive impairment, and the mortality rate for patients with vascular cognitive impairment was similar to that of patients with AD.
Conclusions: Failure to consider vascular cognitive impairment without dementia underestimates the prevalence of impairment and the risk for adverse outcomes associated with vascular cognitive impairment.
Similar articles
-
Mortality and institutionalization in early survivors of stroke: the effects of cognition, vascular mild cognitive impairment, and vascular dementia.J Stroke Cerebrovasc Dis. 2010 Nov-Dec;19(6):485-93. doi: 10.1016/j.jstrokecerebrovasdis.2009.09.006. Epub 2010 Jun 9. J Stroke Cerebrovasc Dis. 2010. PMID: 20538487
-
Cognitive impairment improves the predictive validity of the phenotype of frailty for adverse health outcomes: the three-city study.J Am Geriatr Soc. 2009 Mar;57(3):453-61. doi: 10.1111/j.1532-5415.2008.02136.x. Epub 2009 Feb 22. J Am Geriatr Soc. 2009. PMID: 19245415
-
Mortality in elderly Canadians with and without dementia: a 5-year follow-up.Neurology. 1999 Aug 11;53(3):521-6. doi: 10.1212/wnl.53.3.521. Neurology. 1999. PMID: 10449114
-
Vascular cognitive disorder: a new diagnostic category updating vascular cognitive impairment and vascular dementia.J Neurol Sci. 2004 Nov 15;226(1-2):81-7. doi: 10.1016/j.jns.2004.09.016. J Neurol Sci. 2004. PMID: 15537526 Review.
-
[Vascular dementia and vascular cognitive impairment].Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2004 Apr;26(2):198-200. Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2004. PMID: 15171562 Review. Chinese.
Cited by
-
Demographic and CT scan features related to cognitive impairment in the first year after stroke.J Neurol Neurosurg Psychiatry. 2004 Nov;75(11):1562-7. doi: 10.1136/jnnp.2003.024190. J Neurol Neurosurg Psychiatry. 2004. PMID: 15489388 Free PMC article.
-
Metformin, Rapamycin, or Nicotinamide Mononucleotide Pretreatment Attenuate Cognitive Impairment After Cerebral Hypoperfusion by Inhibiting Microglial Phagocytosis.Front Neurol. 2022 Jun 13;13:903565. doi: 10.3389/fneur.2022.903565. eCollection 2022. Front Neurol. 2022. PMID: 35769369 Free PMC article.
-
Laterality of Attentional Networks in Patients With Cerebral Small Vessel Disease.Front Aging Neurosci. 2020 Mar 20;12:21. doi: 10.3389/fnagi.2020.00021. eCollection 2020. Front Aging Neurosci. 2020. PMID: 32265683 Free PMC article.
-
STROKOG (stroke and cognition consortium): An international consortium to examine the epidemiology, diagnosis, and treatment of neurocognitive disorders in relation to cerebrovascular disease.Alzheimers Dement (Amst). 2016 Nov 18;7:11-23. doi: 10.1016/j.dadm.2016.10.006. eCollection 2017. Alzheimers Dement (Amst). 2016. PMID: 28138511 Free PMC article.
-
Neuroprotection against vascular dementia after acupuncture combined with donepezil hydrochloride: P300 event related potential.Neural Regen Res. 2016 Mar;11(3):460-4. doi: 10.4103/1673-5374.179059. Neural Regen Res. 2016. PMID: 27127486 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources